Skip to main content
Top
Published in: Endocrine 1/2022

01-04-2022 | Magnetic Resonance Imaging | Clinical Management of Endocrine Diseases

Spinal epidural lipomatosis: a rare and frequently unrecognized complication of Cushing syndrome

Authors: Noha Mukhtar, Ali S. Alzahrani

Published in: Endocrine | Issue 1/2022

Login to get access

Abstract

Context

Spinal Epidural Lipomatosis (SEL) is a rare and frequently unrecognized complication of Cushing syndrome (CS). Only nine previous cases of SEL have been described in CS. Here, we present a case of severe SEL and review the literature.

Case report

A 29-year-old man who had severe CS secondary to an ACTH-secreting pituitary macroadenoma. He presented with progressive lower limb weakness over a 2-year period leading to complete paraplegia in the last 4 months. In addition, he had classic symptoms and signs of severe CS. His evaluation confirmed the diagnosis of CS with a 4-fold increase in his daily free urinary cortisol (1190 mg/day), a positive 1-mg dexamethasone suppression test (AM cortisol 729 nmol/l) and an elevated ACTH of 196 ng/dl (10–65). Magnetic resonance imaging (MRI) revealed a 20-mm pituitary adenoma and extensive fat accumulation in the spinal canal extending from C7 to S5 with significant spinal cord compression from T2-T10. The patient underwent an urgent spinal cord decompression surgery. He showed an immediate improvement and was able to walk with crutches 3 weeks later and independently 3 months later. About 13 days after the spinal surgery, he underwent a trans-sphenoidal surgery resulting in eucortisolemia.

Conclusion

SEL is a rare and serious complication of CS. It should be considered in any patient with CS, especially when there is neurological symptoms or disproportionate weakness of the lower limbs. Its management should be individualized but prompt surgical decompression should be considered even in patients with relatively long history of paraparesis.
Literature
3.
go back to reference H. Cushing, The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). J. Neurosurg. 21(4), 318–347 (1964)CrossRef H. Cushing, The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). J. Neurosurg. 21(4), 318–347 (1964)CrossRef
14.
go back to reference C.A. Koch, J.L. Doppman, N.J. Patronas, L.K. Nieman, G.P. Chrousos, Do glucocorticoids cause spinal epidural lipomatosis? When endocrinology and spinal surgery meet. Trends Endocrinol. Metab. 11, 86–90 (2000)CrossRef C.A. Koch, J.L. Doppman, N.J. Patronas, L.K. Nieman, G.P. Chrousos, Do glucocorticoids cause spinal epidural lipomatosis? When endocrinology and spinal surgery meet. Trends Endocrinol. Metab. 11, 86–90 (2000)CrossRef
24.
go back to reference P.H. Benamou, P. Hilliquin, N. Chemla, A. Chevrot, C. Cormier, C.J. Menkès, Epidural lipomatosis not induced by corticosteroid therapy. Three cases including one in a patient with primary Cushing’s disease (review of the literature). Rev. Rhum. Engl. Ed. 63(3), 207–212 (1996)PubMed P.H. Benamou, P. Hilliquin, N. Chemla, A. Chevrot, C. Cormier, C.J. Menkès, Epidural lipomatosis not induced by corticosteroid therapy. Three cases including one in a patient with primary Cushing’s disease (review of the literature). Rev. Rhum. Engl. Ed. 63(3), 207–212 (1996)PubMed
Metadata
Title
Spinal epidural lipomatosis: a rare and frequently unrecognized complication of Cushing syndrome
Authors
Noha Mukhtar
Ali S. Alzahrani
Publication date
01-04-2022
Publisher
Springer US
Published in
Endocrine / Issue 1/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03026-7

Other articles of this Issue 1/2022

Endocrine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.